Search CROs

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Lindus Health is a clinical research organization delivering end-to-end trial execution across Phase 1–2a programs with proprietary AI-driven patient recruitment, integrated site networks, and performance-based pricing. The company has completed 45+ trials with 82% on-time enrollment and operates across the US, UK, and Europe.

• Biomarker Assays
• Genomics & Sequencing Services
• Immunology & Inflammation Services

Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Clinilabs is the leading CNS-focused CRO with 25+ years of expertise in neurotherapeutic clinical trials, offering Phase 1–4 trial management, early-phase development, clinical research units, and MedTech device expertise across psychiatry, neurology, substance use, and rare CNS disorders.

• Bioanalysis
• Clinical Trial Services
• Discovery Research

Leading contract research organization offering preclinical and clinical research services across infectious disease, oncology, and rare diseases, with specialized capabilities in bioanalytical labs, BSL-3 facilities, and in vivo models.

• Biostatistics & Statistical Programming
• Medical Writing
• Regulatory Affairs

Pubrica delivers research design, manuscript writing, statistical analysis, and publication support services to academic researchers, pharmaceutical companies, and clinical research organizations with 20+ years of expertise.

• Bioanalysis
• Central Laboratory Services
• Phase I Clinical Trials

Swiss-based CRO with over 500 completed clinical studies, specializing in Phase I research in healthy volunteers and special populations, supported by centralized clinical labs and analytical capabilities.

Preclinical CRO providing integrated research services including efficacy testing, disease model development, PK/PD, toxicology, biomarker research, and safety assessment across respiratory, ophthalmology, cardiovascular, and neurology therapeutic areas.

• Computational & In-Silico Drug Discovery
• Discovery Research
• High-Throughput Screening

Vipergen provides DNA-encoded library (DEL) screening services for hit identification in early-stage drug discovery, offering both in vitro and in-cell selection formats with high-fidelity libraries containing 500+ million drug-like molecules.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Data-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.

• Analytical Method Development & Validation
• Computational & In-Silico Drug Discovery
• Medicinal Chemistry

Discovery chemistry CRO offering computational, medicinal, synthetic, and analytical chemistry services alongside regulatory support including PDE/OEL assessments, genotoxicity evaluations, and pharmacovigilance for pharmaceutical and biotech clients.

• Computational & In-Silico Drug Discovery
• Discovery Research
• Medicinal Chemistry

Independent chemistry CRO in Dortmund, Germany offering discovery chemistry, custom synthesis, medicinal chemistry, and process development for pharma, biotech, and chemical companies since 1999.

• Biostatistics & Statistical Programming
• Clinical Operations
• Data Management & eClinical

Veridix is the eClinical and AI technology platform of Emmes Group, providing modernized electronic data capture, decentralized trial solutions, and AI-powered agents for clinical data management and biostatistics to support Phase I–IV trials across 90+ countries.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Medidata provides a unified clinical trial platform with AI-driven data management, electronic data capture, patient engagement tools, and real-world data integration to accelerate research across all trial phases.

• Antibody-Drug Conjugate (ADC)
• Biologics (Monoclonal Antibodies)
• Biologics (Other)

Icosagen is an integrated CRDMO (Contract Research, Development & Manufacturing Organization) specializing in antibody discovery, protein production, cell line development, and GMP manufacturing for biologics programs from discovery through commercial scale.

• Analytical Method Development & Validation
• Discovery Research
• In Vitro ADME / DMPK

Medicinal chemistry CRO offering drug discovery, custom organic synthesis, and analytical chemistry services with an all-Ph.D. team and 25+ years of experience.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Global CRO delivering clinical trial management, regulatory consultancy, data management, and medical writing for biotech, pharma, and medical device companies across Phase I–IV studies and real-world evidence programs.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

Full-service preclinical and clinical CRO supporting pharmaceutical, biotechnology, and medical device companies with trial design, site selection, data management, statistical analysis, and medical writing across Asia-Pacific.

• Biostatistics & Statistical Programming
• Clinical Operations
• Phase I Clinical Trials

ISO 9001:2015-certified CRO offering end-to-end clinical research services including Phase I–IV trials, medical writing, biostatistics, data management, and regulatory support across pharmaceuticals, nutraceuticals, devices, and biotech.